Evidence map›Paper›PMID 41466183›Full record

ArticleBMC geriatrics2025

Short-term and long-term reversion rates to normal cognition and their contributing factors among individuals with mild cognitive impairment in a Japanese community: the Hisayama study.

Kaishi Takabatake, Tomoyuki Ohara, Toshifumi Minohara, Taro Nakazawa, Emi Oishi, Yoshihiko Furuta, Satoko Sakata, Mao Shibata, Tomohiro Nakao, Toshiharu Ninomiya

Abstract read
In one paragraph

Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kaishi TakabatakeDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tomoyuki OharaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ohara.tomoyuki.287@m.kyushu-u.ac.jp.
Toshifumi MinoharaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Taro NakazawaDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Emi OishiDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshihiko FurutaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Satoko SakataDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Mao ShibataDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tomohiro NakaoDepartment of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Toshiharu NinomiyaDepartment of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Funding

the Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare of Japan JPMH23FA1006, JPMH24GB1002 and JPMH24FA1005the Japan Agency for Medical Research and Development JP25dk0207053, JP25km0405209, JP25tm0524003, JP25he2202021, and JP25dk0307136the Japan Science and Technology Agency JPMJPF2210the Ministry of Education, Culture, Sports, Science and Technology of Japan JP22K07421, JP23K09692, JP23K09717, JP23K16330, JP23K06787, JP23K09060, and JP25K13589
6 · The paper itself

Abstract

backgroundIndividuals with mild cognitive impairment (MCI) have a high risk of developing dementia, but some remain cognitively stable or even revert to normal cognition (NC), with reported reversion rates varying widely and inconsistent findings regarding contributing factors. The purposes of this study were to investigate the reversion rate from MCI to NC in a community-dwelling older Japanese population and to identify factors associated with reversion.

methodsThree community-based surveys of cognitive function were conducted in the town of Hisayama among residents aged 65 years or older in 2012-2013, 2017-2018, and 2022-2023 (participation rate > 92% for each time range). The 5-year reversion rate from MCI to NC was examined using a pooled cohort, combining two cohorts from the 2012-2013 to the 2017-2018 survey and from the 2017-2018 to the 2022-2023 survey. A logistic regression analysis with generalized estimating equations was used to identify factors associated with reversion to NC based on the pooled cohort data. To evaluate the 10-year reversion rate of MCI, moreover, 171 participants diagnosed with MCI in the 2012-2013 survey were followed for 10 years.

resultsThe 5-year reversion rate from MCI to NC in the pooled cohort was 31.3% (95% confidence interval, 26.9%-36.2%). Younger age, lower systolic blood pressure, absence of diabetes mellitus, absence of instrumental activities of daily living impairment, higher handgrip strength, higher Mini-Mental State Examination (MMSE) score, larger total brain volume, and smaller cerebral white matter lesion volume were significantly associated with reversion to NC. Meanwhile, the 10-year reversion rate from MCI to NC was 18.1% (13.1%-24.6%). Of individuals who reverted from MCI to NC in the 2017-2018 survey, 48.1% (35.0%-61.5%) maintained NC five years later, 32.7% (21.4%-46.4%) returned to MCI, and 5.8% (1.9%-16.4%) progressed to dementia.

conclusionsIn a Japanese community-dwelling older population with MCI, approximately 30% and 18% reverted to NC for 5 years and 10 years, respectively. The prevention and proper management of lifestyle-related diseases and promotion of healthy lifestyle behaviors may play a crucial role in facilitating reversion to NC in older individuals with MCI.

Indexed as

CognitionCognitive DysfunctionAgedAged, 80 and overCohort StudiesEast Asian PeopleFemaleFollow-Up StudiesHumansJapanMaleTime FactorsDementiaMild cognitive impairmentNormal cognitionReversionRisk factors

Identifiers

PMID41466183
PMCPMC12750711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.